EUVIMEDEUVIMED entdecken
VergleichsstudieÜbersichtsarbeitMultizentrische StudieOpen Access · CC BY-NC 4.0

Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review

Moritz Ferch iD, Lukas Galli, Paul Fellinger iD, Sabina Baumgartner-Parzer, Raute Sunder-Plassmann, Konstantin Krychtiuk, Alexandra Kautzky-Willer, Walter Speidl, Yvonne Winhofer

European Journal of Preventive Cardiology · 2025

DOI: 10.1093/eurjpc/zwae331 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Preventive Cardiology, 2025. Verfasst von Moritz Ferch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Cholesterol, LDL, Genetic Testing. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Familial hypercholesterolaemia (FH) is a severely underdiagnosed, inherited disease, causing dyslipidaemia and premature atherosclerotic cardiovascular disease. In order to facilitate screening in a broad clinical spectrum, we aimed to analyse the current yield of routine genetic diagnostics for FH and to evaluate the performance of the Dutch Lipid Clinic Network Score (DLCNS) compared to a single value, the off-treatment LDL-cholesterol exceeding 190 mg/dL. Methods and results We investigated all patients that underwent molecular genotyping routinely performed for FH over a 4-year period in two Austrian specialist lipid clinics. Variants reported in FH-causing genes including LDLR, APOB, PCSK9, LDLRAP, and APOE were collected and classified. For clinical classification, the DLCNS was calculated retrospectively and compared to the original scores documented in patient charts. Additionally, a literature review on comparisons of DLCNS to LDL-C was performed. Of 469 patients tested, 21.3% had a disease-causing variant. A median of 3 out of 8 (excluding genotyping results and LDL-C) DLCNS criteria were unavailable. DLCNS was documented in 48% of cases, with significant discrepancies compared to retrospective scoring (P < 0.001). DLCNS did not outperform off-treatment LDL-C alone (Δ = 0.006; P = 0.660), analogously to several reports identified in the literature. A single cut-off of 190 mg/dL LDL-C compared to DLCNS ≥ 6 showed excellent sensitivity (84.9% vs. 53.8%) and acceptable specificity (39.0% vs. 84.1%).

Conclusion

Missing criteria and severe discrepancies observed between retrospective and on-site scoring by treating physicians were highly prevalent, confirming limited utility of DLCNS in clinical routine and warranting a single off-treatment LDL-C cut-off of 190 mg/dL for enhanced index-case identification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IICholesterol, LDLGenetic TestingHumansAustriaRetrospective StudiesMaleFemaleMiddle AgedPredictive Value of TestsBiomarkersAdultGenetic Predisposition to DiseasePhenotypeMutationNetherlands

Stichwörter der Autor:innen

AustriaDLCNSFamilial HypercholesterolaemiaPerformanceSpectrumYield

Substanzen

Cholesterol, LDLBiomarkers

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Division of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Department for Laboratory Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

ORCID-Profile: Moritz Ferch, Paul Fellinger

Zitieren

APA

Ferch, M., Galli, L., Fellinger, P., Baumgartner-Parzer, S., Sunder-Plassmann, R., Krychtiuk, K., Kautzky-Willer, A., Speidl, W., & Winhofer, Y. (2025). Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwae331

Vancouver

Ferch M, Galli L, Fellinger P, Baumgartner-Parzer S, Sunder-Plassmann R, Krychtiuk K, et al. Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review. European Journal of Preventive Cardiology. 2025. doi:10.1093/eurjpc/zwae331

BibTeX
@article{Ferch2025,
  author = {Ferch, Moritz and Galli, Lukas and Fellinger, Paul and Baumgartner-Parzer, Sabina and Sunder-Plassmann, Raute and Krychtiuk, Konstantin and Kautzky-Willer, Alexandra and Speidl, Walter and Winhofer, Yvonne},
  title = {Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review},
  journal = {European Journal of Preventive Cardiology},
  year = {2025},
  doi = {10.1093/eurjpc/zwae331}
}
Kostenlos starten →